EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikazano 1 - 100 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
Di-, tri- and tetrachlorotetradecane	950-299-5	-		PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)	Details
Nonylphenol, ethoxylated (10-EO) (9016-45-9)	939-993-9	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP)	939-460-0	1471311-26-8		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP)	939-460-0	1471311-26-8		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Nonylphenol, ethoxylated (polymer)	938-618-6	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Zirconia Aluminosilicate Refractory Ceramic Fibres	936-037-2	-		C Carcinogenic (article 57a)	Details
proteases with the exception of those specified elsewhere in this Annex show/hide Proteinase, Tritirachium album serine EC / List no: 254-457-8 \| CAS no: 39450-01-6 Thrombin EC / List no: 232-648-7 \| CAS no: 9002-04-4 Myxobacteralphalyticproteinase EC / List no: - \| CAS no: 12585-31-8 Proteinase, Mucor aspartic EC / List no: 232-975-5 \| CAS no: 9073-79-4 Proteinase, Aspergillus acid EC / List no: 232-796-2 \| CAS no: 9025-49-4 Proteinase, rhizopus acid EC / List no: 812-486-9 \| CAS no: 9074-09-3 Proteinase, microbial acid EC / List no: 256-862-5 \| CAS no: 50936-52-2 Bacillus megaterium protease fermentation product EC / List no: - \| CAS no: 68909-17-1 Bacteria, complex with amylase and proteinase EC / List no: - \| CAS no: 68920-42-3 Proteinase, Streptomyces griseus EC / List no: 232-909-5 \| CAS no: 9036-06-0 Proteinase, Bacillus subtilis serine EC / List no: 266-557-9 \| CAS no: 67051-83-6 Proteinase, Aspergillus parasiticus neutral EC / List no: 254-418-5 \| CAS no: 39335-09-6 Proteinase, aspartic EC / List no: 278-856-1 \| CAS no: 78169-47-8 Amylase, mixture with proteinase EC / List no: 685-079-5 \| CAS no: 9001-11-0 Proteinase, Aspergillus neutral EC / List no: 278-588-5 \| CAS no: 77000-13-6 Proteinase, Bacillus neutral EC / List no: 278-547-1 \| CAS no: 76774-43-1 Proteinase, Bacillus subtilis, sutilain EC / List no: 235-390-3 \| CAS no: 12211-28-8 Proteinase, Bacillus licheniformis serine EC / List no: 279-361-3 \| CAS no: 79986-26-8 Proteinase, oryzin EC / List no: 232-992-8 \| CAS no: 9081-30-5 Proteinase, Bacillus subtilis EC / List no: 257-520-8 \| CAS no: 51931-23-8 Proteinase, microbial alkaline EC / List no: 256-863-0 \| CAS no: 50936-53-3 Proteinase, serine EC / List no: 253-431-3 \| CAS no: 37259-58-8 Proteinase, Agkistrodon serine EC / List no: 232-933-6 \| CAS no: 9046-56-4 Proteinase, Bacillus polymyxa neutral EC / List no: 255-914-4 \| CAS no: 42613-33-2 Proteinase, Myxobacter α-lytic EC / List no: 253-448-6 \| CAS no: 37288-76-9 Proteinase, Bothrops atrox serine EC / List no: 232-918-4 \| CAS no: 9039-61-6 Proteinase, Myxobacter AL-1, II EC / List no: 276-716-4 \| CAS no: 72561-05-8 Proteinase, serine (Tritirachium album) EC / List no: 686-165-5 \| CAS no: 102925-54-2 Aspergillin M EC / List no: - \| CAS no: 42615-60-1 Proteinase, Bacillus subtilis metallo- EC / List no: 232-991-2 \| CAS no: 9080-56-2 Proteinase, bacterial E 30 serine EC / List no: - \| CAS no: 39369-34-1 Proteinase, Bacillus alcalophilus serine EC / List no: 306-090-0 \| CAS no: 95979-76-3 Proteinase, Staphylococcus aureus serine EC / List no: 259-611-8 \| CAS no: 55354-32-0 Proteinase, Bacillus alkaline EC / List no: 232-972-9 \| CAS no: 9073-77-2 Proteinase, Aspergillus niger neutral EC / List no: 254-422-7 \| CAS no: 39346-39-9 Proteinase, submandibular gland serine, A EC / List no: 279-893-6 \| CAS no: 82047-85-6 Proteinase, Endothia aspartic EC / List no: 253-395-9 \| CAS no: 37205-60-0 Amylase, mixed with proteinase, Bacillus cereus-fermented EC / List no: - \| CAS no: 68909-35-3 Proteinase, microbial neutral EC / List no: 232-966-6 \| CAS no: 9068-59-1 Amylase, mixed with proteinase, Bacillus thuringiensis-fermented EC / List no: - \| CAS no: 68909-36-4 Proteinase, Serratia extracellular EC / List no: 253-457-5 \| CAS no: 37312-62-2 Proteinase, Aspergillus oryzae neutral EC / List no: 232-990-7 \| CAS no: 9080-55-1 Proteinase, pancreatic EC / List no: 232-626-7 \| CAS no: 9001-72-3 Proteinase, Aspergillus melleus, semialkaline EC / List no: - \| CAS no: 76106-83-7 Proteinase, Aspergillus alkaline EC / List no: 232-977-6 \| CAS no: 9074-07-1	934-013-6	39450-01-6	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1		Details
Nonylphenolpolyglycolether	932-998-7	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Nonylphenol, ethoxylated (15-EO)	931-756-8	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Nonylphenol, ethoxylated (10-EO)	931-755-2	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Nonylphenol, ethoxylated (8-EO)	931-754-7	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Nonylphenol, ethoxylated (6,5-EO)	931-753-1	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate; reaction mass of DOTE and MOTE	915-270-3	-		R Toxic for reproduction (article 57c)	Details
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole	822-682-6	1417782-03-6	Skin Sens. 1		Details
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2		Details
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine	811-718-6	86347-14-0	Acute Tox. 2; STOT SE 3; STOT SE 1; STOT RE 1		Details
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram	811-438-4	1255734-28-1	Repr. 2; Acute Tox. 4; Skin Sens. 1B		Details
sulfoxaflor (ISO); [methyl(oxo) {1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide	807-366-8	946578-00-3	Acute Tox. 4		Details
4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one; flupyradifurone	804-373-8	951659-40-8	Acute Tox. 4; STOT RE 2		Details
Tris(4-nonylphenyl, branched) phosphite show/hide Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: - Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4 Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8	799-976-5	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Dioctyltin dilaurate, stannane, dioctyl-, bis(coco acyloxy) derivs., and any other stannane, dioctyl-, bis(fatty acyloxy) derivs. wherein C12 is the predominant carbon number of the fatty acyloxy moiety show/hide Dioctyltin dilaurate EC / List no: 222-883-3 \| CAS no: 3648-18-8 Stannane, dioctyl-, bis(coco acyloxy) derivs. EC / List no: 293-901-5 \| CAS no: 91648-39-4 dioctyltin dilaurate; stannane, dioctyl-, bis(coco acyloxy) derivs. EC / List no: - \| CAS no: -	799-973-9	-		R Toxic for reproduction (article 57c)	Details
Phenol, alkylation products (mainly in para position) with C12-rich branched alkyl chains from oligomerisation, covering any individual isomers and/ or combinations thereof (PDDP) show/hide Phenol, 4-dodecyl, branched EC / List no: 640-104-9 \| CAS no: 210555-94-5 [No public or meaningful name is available] EC / List no: - \| CAS no: 27459-10-5 Phenol, tetrapropylene- EC / List no: - \| CAS no: 57427-55-1 Phenol, (tetrapropenyl) derivatives EC / List no: 616-100-8 \| CAS no: 74499-35-7 Phenol, 4-isododecyl- EC / List no: 608-055-8 \| CAS no: 27147-75-7 Phenol, dodecyl-, branched EC / List no: 310-154-3 \| CAS no: 121158-58-5	799-972-3	-		R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health)	Details
Medium-chain chlorinated paraffins (MCCP) UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17 show/hide Tetradecane, chloro derivs. EC / List no: - \| CAS no: 198840-65-2 di-, tri- and tetrachlorotetradecane EC / List no: 950-299-5 \| CAS no: - Alkanes, C14-16, chloro EC / List no: 701-376-5 \| CAS no: 1372804-76-6 Alkanes, C14-17, chloro EC / List no: 287-477-0 \| CAS no: 85535-85-9	799-971-8	-		PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)	Details
2-(4-tert-Butylbenzyl)propionaldehyde and its individual stereoisomers show/hide (2R)-3-(4-tert-butylphenyl)-2-methylpropanal EC / List no: - \| CAS no: 75166-31-3 (2S)-3-(4-tert-butylphenyl)-2-methylpropanal EC / List no: - \| CAS no: 75166-30-2 2-(4-tert-butylbenzyl)propionaldehyde EC / List no: 201-289-8 \| CAS no: 80-54-6	799-970-2	-		R Toxic for reproduction (article 57c)	Details
Potassium perfluoroheptanoate	701-468-5	21049-36-5		R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)	Details
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; Lact.; STOT RE 2		Details
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one	701-394-3	1782069-81-1		END Endocrine disrupting properties (Article 57(f) - human health)	Details
Alkanes, C14-16, chloro	701-376-5	1372804-76-6		PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)	Details
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts	701-271-4	-	Repr. 1B; Eye Irrit. 2		Details
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy} ethyl methyl carbonate; tolpyralate	701-225-3	1101132-67-5	Carc. 2; Repr. 2; STOT RE 2		Details
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-162-1	-	Repr. 1B		Details
6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-118-1	2156592-54-8	Repr. 1B; Eye Irrit. 2		Details
phenol, 3-dodecyl-, branched	701-107-1	1801269-77-1	Repr. 1B; Skin Corr. 1C; Eye Dam. 1		Details
phenol, 2-dodecyl-, branched	701-105-0	1801269-80-6	Repr. 1B; Skin Corr. 1C; Eye Dam. 1		Details
Oligomerisation and alkylation reaction products of 2-phenylpropene and phenol show/hide Phenol, methylstyrenated EC / List no: 270-966-8 \| CAS no: 68512-30-1	700-960-7	-		VPVB very Persistent and very Bioaccumulative (article 57e)	Details
Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoate	700-242-3	62037-80-3		E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)	Details
2-methyl-1,2-benzothiazol-3(2H)-one; [MBIT]	695-989-4	2527-66-4	Acute Tox. 4; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A		Details
(5-chloro-2-methoxy-4-methyl-3-pyridyl) (4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone	692-456-8	688046-61-9	Carc. 2		Details
benzovindiflupyr (ISO); N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide	691-719-4	1072957-71-1	Acute Tox. 3		Details
N-{2-[[1,1'-bi (cyclopropyl)]-2-yl] phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxane	688-331-2	874967-67-6	Carc. 2		Details
2-{2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethoxy}ethanol	687-833-9	1119449-38-5		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol	687-832-3	1119449-37-4		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
di-L-para-menthene	686-814-2	34363-01-4	Skin Irrit. 2; Skin Sens. 1		Details
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine	682-791-8	160430-64-8	Repr. 2; Acute Tox. 3		Details
tetracopper hexahydroxide sulphate hydrate	682-362-5	12527-76-3	Acute Tox. 4		Details
trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl (hydroxy) methylene]-3,5-dioxocyclohexanecarboxylate	680-302-2	95266-40-3	STOT RE 2; Skin Sens. 1B		Details
diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate	680-227-5	71449-78-0	Skin Sens. 1		Details
amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide	672-776-4	348635-87-0	Carc. 2; Eye Irrit. 2		Details
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate	642-974-5	400882-07-7	Carc. 2; Skin Sens. 1A		Details
hydroxyisohexyl 3-cyclohexene carboxaldehyde (INCI); reaction mass of 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde and 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde	641-410-5	130066-44-3	Skin Sens. 1A		Details
Cadmium chloride, hydrate (2:5)	640-998-0	7790-78-5		C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
phenol, 4-dodecyl-, branched	640-104-9	210555-94-5	Repr. 1B; Skin Corr. 1C; Eye Dam. 1	R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health)	Details
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)	639-478-6	182635-99-0	Acute Tox. 4; Skin Corr. 1B		Details
4-(3-ethylheptan-2-yl)phenol	635-696-0	186825-39-8		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
4-(3,6-dimethylheptan-3-yl)phenol	635-391-2	142731-63-3		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
4-(3,5-dimethylheptan-3-yl)phenol	635-389-1	186825-36-5		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
4-(2,6-dimethylheptan-2-yl)phenol	635-388-6	521947-27-3		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate	635-361-9	243973-20-8	Repr. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Sens. 1A		Details
Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazam	632-619-2	881685-58-1	Carc. 2; Repr. 1B; Skin Sens. 1B		Details
methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate	630-448-8	62610-77-9	Acute Tox. 4; Skin Sens. 1		Details
4-nitrosomorpholine	627-564-6	59-89-2	Carc. 1B; Muta. 2; STOT RE 1		Details
Sulphuric acid, cadmium salt (1:1), unspecified hydration rate	626-360-4	15244-35-6		C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
3-bromo-2,2-bis(bromomethyl)propan1-ol	622-370-8	1522-92-5	Carc. 1B; Muta. 2	C Carcinogenic (article 57a)	Details
4-tert-Octylphenol monoethoxylate	621-345-9	2315-67-5		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated	621-341-7	2315-61-9		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
erionite	620-440-2	12510-42-8	Carc. 1A		Details
diclobutrazole (ISO);(R, R)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol	620-436-0	75736-33-3	Eye Irrit. 2		Details
propylenethiourea	620-432-9	2122-19-2	Repr. 2; Acute Tox. 4		Details
guazatine (ISO)	620-427-1	108173-90-6	Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1		Details
azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one	620-425-0	68049-83-2	Repr. 1B; STOT RE 2		Details
dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol	620-422-4	4097-36-3	Acute Tox. 3		Details
2,4,6-trinitroanisole	620-419-8	606-35-9	Expl. 1.1; Acute Tox. 4		Details
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride	620-411-4	123748-85-6	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1		Details
kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate	620-410-9	4234-79-1	Acute Tox. 3; Acute Tox. 4		Details
dichloroacetylene	620-404-6	7572-29-4	Unst. Expl.; Carc. 2; STOT RE 2		Details
basic phenylmercury nitrate	620-403-0	8003-05-2	Acute Tox. 3; STOT RE 1; Skin Corr. 1B		Details
lithium nickel dioxide	620-400-4	12031-65-1	Carc. 1A; STOT RE 1; Skin Sens. 1		Details
cobalt nickel oxide	620-395-9	12737-30-3	Carc. 1A; STOT RE 1; Skin Sens. 1		Details
dimethyl 4-(methylthio)phenyl phosphate	620-379-1	3254-63-5	Acute Tox. 1; Acute Tox. 2		Details
demeton	620-378-6	8065-48-3	Acute Tox. 1; Acute Tox. 2		Details
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate	620-377-0	13067-93-1	Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2		Details
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate	620-370-2	2703-37-9	Acute Tox. 2; Acute Tox. 1		Details
triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphonic diamide	620-368-1	1031-47-6	Acute Tox. 1; Acute Tox. 2		Details
propineb (ISO); polymeric zinc propylenebis(dithiocarbamate)	620-365-5	9016-72-2	Acute Tox. 4; STOT RE 2; Skin Sens. 1		Details
methyl 3,4-dichlorophenylcarbanilate; SWEP.	620-362-9	1918-18-9	Acute Tox. 4		Details
bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate	620-359-2	8065-36-9	Acute Tox. 3		Details
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA	620-358-7	140-41-0	Carc. 2; Eye Irrit. 2; Skin Irrit. 2		Details
3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide; fluxapyroxad	620-041-3	907204-31-3	Lact.		Details
5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1H-pyrazole-4-carboxamide; 2'-[(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen	619-823-7	494793-67-8	Carc. 2		Details
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one	619-396-7	99129-21-2	Acute Tox. 4; Skin Sens. 1		Details
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione	619-394-6	99105-77-8	Repr. 2; STOT RE 2; Skin Sens. 1A		Details
fosthiazate (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate	619-377-3	98886-44-3	Acute Tox. 3; Acute Tox. 4; Skin Sens. 1		Details
ethametsulfuron-methyl (ISO); methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl] carbamoyl}sulfamoyl) benzoate	619-290-0	97780-06-8	Eye Irrit. 2		Details
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol	619-020-1	94361-06-5	Repr. 1B; Acute Tox. 3; STOT RE 2		Details
prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea	619-000-2	94125-34-5	Acute Tox. 4		Details
Polyethylene glycol mono(tert-octylph-enyl) ether9036-19-5	618-541-1	9036-19-5		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
cellulose nitrate; nitrocellulose	618-392-2	9004-70-0	Expl. 1.1		Details
2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol	618-344-0	9002-93-1		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	618-075-9	87820-88-0	Carc. 2; Acute Tox. 4		Details
S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %)	618-004-1	87392-12-9	Skin Sens. 1		Details

Prikazano 1 - 100 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items